Qualifying for GLP-1 therapy when following keto Qualifying for GLP-1 prescriptions typically requires a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia
Personalised Treatment Experience Tailored to individual goals and skin assessment
I have lost a decent amount of weight without a big crazy unhealthy change
Integrating software and smart devices for personalized monitoring and adherence can increase loyalty and improve outcomes especially in self-pay contexts
Nearly a dozen oral GLP-1 molecules are in various stages of development at Chinese pharma firms, including Hengrui, Huadong, Innovent Biologics and Ascletis
Preventing atherosclerosis In a study that examined the effects exerted by liraglutide on the endothelium in mice models with early onset, low-burden atherosclerotic disease, liraglutide treatment in apolipoprotein E deficient (ApoE / ) mice inhibited the progression of early onset, low-burden atherosclerotic disease and enhanced plaque stability in a partially GLP-1R-dependent manner, without significantly affecting late onset, high-burden atherosclerotic disease